Molecular testing for thyroid nodules: the experience at McGill University teaching hospitals in Canada

M Rajab, RJ Payne, VI Forest, M Pusztaszeri - Cancers, 2022 - mdpi.com
Simple Summary The aim of this review is to provide a general overview about the
molecular markers (mutations and alterations) of thyroid cancers, present several molecular …

Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities

A Imperiale, V Berti, M Burgy, RL Cazzato… - Reviews in Endocrine …, 2024 - Springer
Due to its rarity and non-specific clinical presentation, accurate diagnosis, and optimal
therapeutic strategy of medullary thyroid carcinoma (MTC) remain challenging. Molecular …

Molecular profiling of 50 734 Bethesda III-VI thyroid nodules by ThyroSeq v3: implications for personalized management

S Chiosea, SP Hodak, L Yip, D Abraham… - The Journal of …, 2023 - academic.oup.com
Context Comprehensive genomic analysis of thyroid nodules for multiple classes of
molecular alterations detected in a large series of fine needle aspiration (FNA) samples has …

Improved survival after primary tumor resection in distant metastasis medullary thyroid carcinoma: a population-based cohort study with propensity score matching

Z Tao, X Deng, Z Ding, B Guo, Y Fan - Scientific Reports, 2024 - nature.com
Few studies have investigated the impact of primary tumor resection (PTR) on patients with
distant metastasis medullary thyroid carcinoma (DMMTC). This population-based study aims …

PD-L1 Expression and its modulating factors in anaplastic thyroid carcinoma: a multi-institutional study

S Agarwal, CK Jung, P Gaddam… - The American Journal …, 2024 - journals.lww.com
Anti-PD immunotherapy is currently under investigation in anaplastic thyroid carcinoma
(ATC). Tumor cell surface PD-L1 expression is considered predictive of therapeutic …

[HTML][HTML] Update on current diagnosis and management of anaplastic thyroid carcinoma

ET Pavlidis, IN Galanis, TE Pavlidis - World Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Well-differentiated thyroid carcinoma has a favorable prognosis with a 5-year survival rate of
over 95%. However, the undifferentiated or anaplastic type accounting for< 0.2%, usually in …

Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective

F Pitoia, RS Scheffel, I Califano, A Gauna… - Reviews in Endocrine …, 2024 - Springer
Radioiodine (RAI) refractory differentiated thyroid cancer is an uncommon and challenging
situation that requires a multidisciplinary approach to therapeutic strategies. The definition of …

US risk stratification system for follicular thyroid neoplasms

J Li, C Li, XH Zhou, JP Huang, P Yang, Y Cang, H Zhai… - Radiology, 2023 - pubs.rsna.org
Background Preoperative assessment of follicular thyroid neoplasms is challenging using
the current US risk stratification systems (RSSs) that are applicable to papillary thyroid …

Comparison of endoscopic bilateral areolar and robotic-assisted bilateral axillo-breast approach thyroidectomy in differentiated thyroid carcinoma: a propensity …

X Fu, Y Ma, Y Hou, Y Liu, L Zheng - BMC surgery, 2023 - Springer
Background Robot-assisted and endoscopic thyroidectomy are superior to conventional
open thyroidectomy in improving cosmetic outcomes and postoperative quality of life. The …

Transoral endoscopic and robotic thyroidectomy for thyroid cancer: the mid-term oncological outcome

YH Chen, WP Chao, SH Wang, YT Huang, SC Ng - Surgical Endoscopy, 2023 - Springer
Background Traditional open thyroidectomy is the surgical standard for thyroid cancer;
however, it inevitably leaves a visible scar on the neck and affects the patient's quality of life …